Cargando…
An Evaluation of Blood Compatibility of Silver Nanoparticles
Silver nanoparticles (AgNPs) have tremendous potentials in medical devices due to their excellent antimicrobial properties. Blood compatibility should be investigated for AgNPs due to the potential blood contact. However, so far, most studies are not systematic and have not provided insights into th...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857076/ https://www.ncbi.nlm.nih.gov/pubmed/27145858 http://dx.doi.org/10.1038/srep25518 |
_version_ | 1782430592971833344 |
---|---|
author | Huang, He Lai, Wenjia Cui, Menghua Liang, Ling Lin, Yuchen Fang, Qiaojun Liu, Ying Xie, Liming |
author_facet | Huang, He Lai, Wenjia Cui, Menghua Liang, Ling Lin, Yuchen Fang, Qiaojun Liu, Ying Xie, Liming |
author_sort | Huang, He |
collection | PubMed |
description | Silver nanoparticles (AgNPs) have tremendous potentials in medical devices due to their excellent antimicrobial properties. Blood compatibility should be investigated for AgNPs due to the potential blood contact. However, so far, most studies are not systematic and have not provided insights into the mechanisms for blood compatibility of AgNPs. In this study, we have investigated the blood biological effects, including hemolysis, lymphocyte proliferation, platelet aggregation, coagulation and complement activation, of 20 nm AgNPs with two different surface coatings (polyvinyl pyrrolidone and citrate). Our results have revealed AgNPs could elicit hemolysis and severely impact the proliferation and viability of lymphocytes at all investigated concentrations (10, 20, 40 μg/mL). Nevertheless, AgNPs didn’t show any effect on platelet aggregation, coagulation process, or complement activation at up to ~40 μg/mL. Proteomic analysis on AgNPs plasma proteins corona has revealed that acidic and small molecular weight blood plasma proteins were preferentially adsorbed onto AgNPs, and these include some important proteins relevant to hemostasis, coagulation, platelet, complement activation and immune responses. The predicted biological effects of AgNPs by proteomic analysis are mostly consistent with our experimental data since there were few C3 components on AgNPs and more negative than positive factors involving platelet aggregation and thrombosis. |
format | Online Article Text |
id | pubmed-4857076 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-48570762016-05-18 An Evaluation of Blood Compatibility of Silver Nanoparticles Huang, He Lai, Wenjia Cui, Menghua Liang, Ling Lin, Yuchen Fang, Qiaojun Liu, Ying Xie, Liming Sci Rep Article Silver nanoparticles (AgNPs) have tremendous potentials in medical devices due to their excellent antimicrobial properties. Blood compatibility should be investigated for AgNPs due to the potential blood contact. However, so far, most studies are not systematic and have not provided insights into the mechanisms for blood compatibility of AgNPs. In this study, we have investigated the blood biological effects, including hemolysis, lymphocyte proliferation, platelet aggregation, coagulation and complement activation, of 20 nm AgNPs with two different surface coatings (polyvinyl pyrrolidone and citrate). Our results have revealed AgNPs could elicit hemolysis and severely impact the proliferation and viability of lymphocytes at all investigated concentrations (10, 20, 40 μg/mL). Nevertheless, AgNPs didn’t show any effect on platelet aggregation, coagulation process, or complement activation at up to ~40 μg/mL. Proteomic analysis on AgNPs plasma proteins corona has revealed that acidic and small molecular weight blood plasma proteins were preferentially adsorbed onto AgNPs, and these include some important proteins relevant to hemostasis, coagulation, platelet, complement activation and immune responses. The predicted biological effects of AgNPs by proteomic analysis are mostly consistent with our experimental data since there were few C3 components on AgNPs and more negative than positive factors involving platelet aggregation and thrombosis. Nature Publishing Group 2016-05-05 /pmc/articles/PMC4857076/ /pubmed/27145858 http://dx.doi.org/10.1038/srep25518 Text en Copyright © 2016, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Huang, He Lai, Wenjia Cui, Menghua Liang, Ling Lin, Yuchen Fang, Qiaojun Liu, Ying Xie, Liming An Evaluation of Blood Compatibility of Silver Nanoparticles |
title | An Evaluation of Blood Compatibility of Silver Nanoparticles |
title_full | An Evaluation of Blood Compatibility of Silver Nanoparticles |
title_fullStr | An Evaluation of Blood Compatibility of Silver Nanoparticles |
title_full_unstemmed | An Evaluation of Blood Compatibility of Silver Nanoparticles |
title_short | An Evaluation of Blood Compatibility of Silver Nanoparticles |
title_sort | evaluation of blood compatibility of silver nanoparticles |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857076/ https://www.ncbi.nlm.nih.gov/pubmed/27145858 http://dx.doi.org/10.1038/srep25518 |
work_keys_str_mv | AT huanghe anevaluationofbloodcompatibilityofsilvernanoparticles AT laiwenjia anevaluationofbloodcompatibilityofsilvernanoparticles AT cuimenghua anevaluationofbloodcompatibilityofsilvernanoparticles AT liangling anevaluationofbloodcompatibilityofsilvernanoparticles AT linyuchen anevaluationofbloodcompatibilityofsilvernanoparticles AT fangqiaojun anevaluationofbloodcompatibilityofsilvernanoparticles AT liuying anevaluationofbloodcompatibilityofsilvernanoparticles AT xieliming anevaluationofbloodcompatibilityofsilvernanoparticles AT huanghe evaluationofbloodcompatibilityofsilvernanoparticles AT laiwenjia evaluationofbloodcompatibilityofsilvernanoparticles AT cuimenghua evaluationofbloodcompatibilityofsilvernanoparticles AT liangling evaluationofbloodcompatibilityofsilvernanoparticles AT linyuchen evaluationofbloodcompatibilityofsilvernanoparticles AT fangqiaojun evaluationofbloodcompatibilityofsilvernanoparticles AT liuying evaluationofbloodcompatibilityofsilvernanoparticles AT xieliming evaluationofbloodcompatibilityofsilvernanoparticles |